Bisker-Leib Vered

Bisker-Leib Vered is listed in filings as CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 9, 2024, including 3 public disclosures. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX). The current snapshot covers public activity from Nov 21, 2023 to Feb 9, 2024. Reported amounts are shown as $71.3K to $96.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.